NMS Consulting Selected as Strategic Advisor to Cerebain Biotech Corp. for Acquisition Project

BEVERLY HILLS, CA / ACCESSWIRE / October 6, 2020 / NMS Consulting, Inc. (“NMS”) is pleased to announce that it has been selected as strategic advisor by Cerebain Biotech Cop. (OTCPINK:CBBT) (“Cerebain”) for its planned acquisition of PKG, Inc. (“PKG”).

As part of the initial scope of services, NMS shall provide management consulting services related to the formal due diligence of the PKG operations and financials in addition to analysis related to revenue and cost synergies/savings, human capital and performance optimization, tax advisory, and mitigation strategy, risk management strategy, transaction and financing structuring to ensure optimal benefits to Cerebain and its shareholders. Additional services shall include post-merger integration, revenue growth strategies, market entry and expansion, digital transformation, cyber-security, and data privacy.

Trevor M. Saliba, Managing Partner and Global Head of Private Equity, M&A, and Strategy of NMS said, “We are very excited to continue working with Cerebain on

Read More